NIBEC CO., LTD. Logo

NIBEC CO., LTD.

Develops peptide-based biomaterials for regenerative medicine, dental, and cosmetic uses.

138610 | KO

Overview

Corporate Details

ISIN(s):
KR7138610001
LEI:
Country:
South Korea
Address:
충청북도 진천군 이월면 밤디길 116 이월전기전자농공1단지, 진천군

Description

NIBEC CO., LTD. is a biotechnology company specializing in the research, development, and commercialization of healthcare solutions centered on proprietary peptide technology. The company's core activities involve the manufacturing of tissue regenerative biomaterials, such as dental bone grafts and collagen-based products, as well as biomaterial-based medical devices. In addition to its focus on regenerative medicine, NIBEC develops and markets a range of dental care and cosmetic products. The company is also actively engaged in the research and development of novel peptide-based drugs and bio-fusion technologies to address various therapeutic needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2019-06-18 00:00
증권발행실적보고서
Korean 59.4 KB
2019-06-13 00:00
주식등의대량보유상황보고서(일반)
Korean 85.5 KB
2019-06-12 00:00
유상증자또는주식관련사채등의청약결과(자율공시)
Korean 10.5 KB
2019-06-05 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 23.0 KB
2019-06-04 00:00
유상증자최종발행가액확정
Korean 12.1 KB
2019-05-31 00:00
주식등의대량보유상황보고서(약식)
Korean 59.8 KB
2019-05-31 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 23.8 KB
2019-05-27 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 23.8 KB
2019-05-24 00:00
주식등의대량보유상황보고서(약식)
Korean 61.1 KB
2019-05-22 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.1 KB
2019-05-22 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.2 KB
2019-05-22 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.2 KB
2019-05-22 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.2 KB
2019-05-22 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.3 KB
2019-05-22 00:00
주식등의대량보유상황보고서(일반)
Korean 101.0 KB

Automate Your Workflow. Get a real-time feed of all NIBEC CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NIBEC CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NIBEC CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.